Unspecified infection of urinary tract in pregnancy, second trimester
ICD-10 O23.42 is a billable code used to indicate a diagnosis of unspecified infection of urinary tract in pregnancy, second trimester.
Unspecified urinary tract infections (UTIs) during pregnancy can pose significant risks to both the mother and fetus, particularly during the second trimester when fetal development is critical. UTIs are common in pregnant women due to physiological changes, including increased urinary stasis and hormonal influences that can alter the urinary tract's normal flora. Symptoms may include dysuria, frequency, urgency, and suprapubic pain. However, some women may be asymptomatic, making screening essential. Diagnosis typically involves urinalysis and culture to identify the causative organism. Treatment is crucial to prevent complications such as pyelonephritis, which can lead to preterm labor and low birth weight. Antibiotic therapy must be carefully selected, considering safety profiles for use during pregnancy. Commonly prescribed antibiotics include nitrofurantoin and amoxicillin, which are generally considered safe in pregnancy, while others like tetracyclines should be avoided. Proper management of UTIs in pregnancy is vital to ensure maternal and fetal health.
Documentation must include patient history, presenting symptoms, urinalysis results, and treatment plans.
A pregnant patient presents with dysuria and frequency; urinalysis shows bacteria, leading to a diagnosis of UTI.
Coders must ensure that the diagnosis reflects the specific trimester and any complications that may arise.
Detailed documentation of maternal and fetal health, including any high-risk factors.
A patient with a history of recurrent UTIs presents for monitoring during pregnancy.
High-risk pregnancies may require additional documentation regarding the management of UTIs and their impact on fetal health.
Used when a urine culture is performed to confirm a UTI diagnosis in a pregnant patient.
Documentation must include the reason for the culture and any relevant clinical findings.
Obstetricians should ensure that cultures are performed in accordance with guidelines for pregnant patients.
Common symptoms include dysuria, increased urinary frequency, urgency, and suprapubic pain. Some women may be asymptomatic, making routine screening important.
Antibiotics such as nitrofurantoin and amoxicillin are generally considered safe during pregnancy, while others like tetracyclines should be avoided due to potential risks to fetal development.
